Comparision of the effect of photodynamic therapy associated with scaling and scaling alone in aggrissive gingival disease

Comparision of the clinical and microbiological effects of photodynamic therapy as an adjunctive treatment with scaling and root planning with scaling and root planning alone in aggressive periodontitis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201211277128N3

Enrollment

Registered

2012-12-23

Start date

2012-07-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

aggresive periodontitis. Juvenile periodontosis

Interventions

Intervention 1: control: scaling and rootplanning as full mouth approach in all quadrants. Intervention 2: intervention: Scaling and root planning with photodynamic teraphy in the selected teeth with

Treatment - Other

control: scaling and rootplanning as full mouth approach in all quadrants

intervention: Scaling and root planning with photodynamic teraphy in the selected teeth with PD=4mm after application of photosensitizer and then the irradition of the laser with wavelength 670-690 nm

Eligibility

Sex/Gender

All

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: A total of 28 patients; with an age range of 18-45 years, suffering from aggressive periodontitis; The subjects had at least 12 teeth and at least 3 teeth in each quadrant and one tooth with CAL=4mm in each quadrant. Exclusion criteria: systemic disease; conditions which delay would healing; a history of radiotherapy or immune-suppressive treatment modalities; pregnancy or breast-feeling; use of systemic antibiotics during the 6 previous months; history of scaling and root planning during the previous year.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Clinical attachment level (CAL). Timepoint: baseline and 3 month later. Method of measurement: milimeter distance from CEJ to bottom of pocket with a periodontal probe.	—

Secondary

Measure	Time frame
Probing Depth (PD). Timepoint: baseline and 3 month later. Method of measurement: milimeter distance from gingival margin to botom of pocket.;Bleeding on probing (BOP). Timepoint: baseline and 3 month later. Method of measurement: presence or absence of bleeding 30 s after probing.;Recession (REC). Timepoint: baseline and 3 month later. Method of measurement: milimeter distance from CEJ to gingival margin.;Plaque Index (PI). Timepoint: baseline and 3 month later. Method of measurement: Oleary Plaque Index.;Gingival Index(GI). Timepoint: baseline and 3 month later. Method of measurement: Loe & Silness introduced it base on imflamation and ademe and redness and important object of it, is bleeding.;Quantitive measurment of Aa (Aggregatibacter actinomycetemcomitans). Timepoint: baseline and 3 month later. Method of measurement: real time PCR by special laboratory kits of real-time PCR.	—

Measure

Time frame

Probing Depth (PD). Timepoint: baseline and 3 month later. Method of measurement: milimeter distance from gingival margin to botom of pocket.;Bleeding on probing (BOP). Timepoint: baseline and 3 month later. Method of measurement: presence or absence of bleeding 30 s after probing.;Recession (REC). Timepoint: baseline and 3 month later. Method of measurement: milimeter distance from CEJ to gingival margin.;Plaque Index (PI). Timepoint: baseline and 3 month later. Method of measurement: Oleary Plaque Index.;Gingival Index(GI). Timepoint: baseline and 3 month later. Method of measurement: Loe & Silness introduced it base on imflamation and ademe and redness and important object of it, is bleeding.;Quantitive measurment of Aa (Aggregatibacter actinomycetemcomitans). Timepoint: baseline and 3 month later. Method of measurement: real time PCR by special laboratory kits of real-time PCR.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Ilnaz Farhoudi

Tabriz University of Medical Science

shirmohamadia@tbzmed.ac.irelnaz.farhoodi@yahoo.com+98 41 1335 5966

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026